MedTrace Logo

Peer Support Workers Feasibility Study

NCT07030192 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3181

Last updated 2025-11-21

No results posted yet for this study

Summary

Many people with high-risk opioid use visit emergency departments (EDs), facing a high risk of death if they leave before completing care. Peer support workers (Peer) - people with lived experience of substance use - may improve patient comfort, reduce early departures, and potentially lower mortality rates. This study aims to evaluate how a hospital-implemented ED Peer program can enhance patient support, reduce barriers to care, and provide harm-reduction resources in a person-centred and trauma-informed manner. The study will also validate the outcome and obtain preliminary estimates of the benefits of decreasing patients who leave the ED before completing care.

Conditions

  • Substance Use Disorder (SUD)

Interventions

BEHAVIORAL

Peer support service

Peers approach identified patients who could potentially benefit from peer support services. Peers offer a range of supports tailored to individual patients' needs, which include referrals to clinical and social support services (e.g., social work, addictions specialist, Indigenous patient navigator, community-based addictions resources), resources (e.g., blankets, food, naloxone kit, sterile drug use supplies, information brochures), providing emotional support, and liaising between patients and healthcare providers to communicate information about patients' condition and ED trajectory. Peer support workers share their personal experiences to guide patients through their ED visit and to facilitate awareness and understanding of available resources.

Sponsors & Collaborators

  • Vancouver Coastal Health Research Institute

    collaborator OTHER

  • BC Centers for Disease Control

    collaborator UNKNOWN

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Jessica Moe, MD · University of British Columbia

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-23
Primary Completion
2027-09-30
Completion
2027-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07030192 on ClinicalTrials.gov